AARTIDRUGSBSEAarti Drugs LtdLowNeutral
Announced Fri, 8 May · 19:17 IST

Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve Audited Financial results for the ....

AARTIDRUGS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.4%1-day move
₹386.50
prior close
₹387.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.5-0.6-0.9-2.1-3.4-5.0-6.3-5.0-5.3-1.4-1.5-5.0+2.3
Up moveDown movePending
AI summary

Aarti Drugs Ltd has informed exchanges that a Board meeting is scheduled for May 15, 2026 to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. The company has notified that its trading window will remain closed until 48 hours after the results are declared. This is a standard regulatory intimation under SEBI Listing Regulations and does not contain any preliminary financial figures or commentary. Investors should note that this filing merely announces the timing of a scheduled event rather than disclosing actual financial performance.

Likely market impact

This is a routine pre-result announcement. No trading positions should be initiated based on this intimation as no financial data has been released. Market participants should await the actual results announcement expected around May 15, 2026.